Announcements
- Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
- Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023
- Immutep’s Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancer
Key statistics
On Friday, Immutep Ltd (YP1B:FRA) closed at 0.244, -14.49% below its 52-week high of 0.2854, set on May 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.244 |
---|---|
High | 0.244 |
Low | 0.244 |
Bid | 0.244 |
Offer | 0.278 |
Previous close | 0.244 |
Average volume | 31.54 |
---|---|
Shares outstanding | 1.19bn |
Free float | 1.14bn |
P/E (TTM) | -- |
Market cap | 534.98m AUD |
EPS (TTM) | -0.0394 AUD |
Data delayed at least 15 minutes, as of Jun 07 2024 08:06 BST.
More ▼